APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-Assisted Drug Discovery Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI-Assisted Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026192 pages

Choose your research edition.

Industry ResearchAI-Assisted Drug Discovery Software Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-Assisted Drug Discovery Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI-Assisted Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-Assisted Drug Discovery Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-Assisted Drug Discovery Software Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

The global AI-Assisted Drug Discovery Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI-Assisted Drug Discovery Software include AIDDISON, Atomwise Inc, BenevolentAI, BullFrog AI, Cyclica, Exscientia, Genesis Therapeutics Inc, Insilico Medicine and Recursion Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI-Assisted Drug Discovery Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-Assisted Drug Discovery Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-Assisted Drug Discovery Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI-Assisted Drug Discovery Software market size, projected growth trends, production technologies, key applications, and end-use industries.

AI-Assisted Drug Discovery Software Segment by Company

AIDDISON

Atomwise Inc

BenevolentAI

BullFrog AI

Cyclica

Exscientia

Genesis Therapeutics Inc

Insilico Medicine

Recursion Pharmaceuticals

Verge Genomics

AI-Assisted Drug Discovery Software Segment by Type

On Premise Software

Cloud-Based Software

AI-Assisted Drug Discovery Software Segment by Application

Biopharmaceuticals

Pharmaceuticals

Others

AI-Assisted Drug Discovery Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Assisted Drug Discovery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-Assisted Drug Discovery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Assisted Drug Discovery Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI-Assisted Drug Discovery Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-Assisted Drug Discovery Software industry.

Chapter 3: Detailed analysis of AI-Assisted Drug Discovery Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-Assisted Drug Discovery Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of On Premise Software Table 3. Key Players of Cloud-Based Software Table 4. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biopharmaceuticals Table 6. Key Players of Pharmaceuticals Table 7. Key Players of Others Table 8. Global AI-Assisted Drug Discovery Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global AI-Assisted Drug Discovery Software Market Size by Region (2021-2026) & (US$ Million) Table 10. Global AI-Assisted Drug Discovery Software Market Share by Region (2021-2026) Table 11. Global AI-Assisted Drug Discovery Software Market Size by Region (2027-2032) & (US$ Million) Table 12. Global AI-Assisted Drug Discovery Software Market Share by Region (2027-2032) Table 13. AI-Assisted Drug Discovery Software Industry Trends Table 14. AI-Assisted Drug Discovery Software Industry Drivers Table 15. AI-Assisted Drug Discovery Software Industry Opportunities and Challenges Table 16. AI-Assisted Drug Discovery Software Industry Restraints Table 17. Global AI-Assisted Drug Discovery Software Revenue by Company (US$ Million) & (2021-2026) Table 18. Global AI-Assisted Drug Discovery Software Revenue Market Share by Company (2021-2026) Table 19. Global AI-Assisted Drug Discovery Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global AI-Assisted Drug Discovery Software Key Company Head Office and Area Served Table 21. Global AI-Assisted Drug Discovery Software Company, Product Type & Application Table 22. Global AI-Assisted Drug Discovery Software Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global AI-Assisted Drug Discovery Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global AI-Assisted Drug Discovery Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) & (US$ Million) Table 27. Global AI-Assisted Drug Discovery Software Market Size by Type (2027-2032) & (US$ Million) Table 28. Global AI-Assisted Drug Discovery Software Revenue Market Share by Type (2021-2026) Table 29. Global AI-Assisted Drug Discovery Software Revenue Market Share by Type (2027-2032) Table 30. Global AI-Assisted Drug Discovery Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) & (US$ Million) Table 32. Global AI-Assisted Drug Discovery Software Market Size by Application (2027-2032) & (US$ Million) Table 33. Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2021-2026) Table 34. Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2027-2032) Table 35. AIDDISON Company Information Table 36. AIDDISON Business Overview Table 37. AIDDISON AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AIDDISON AI-Assisted Drug Discovery Software Product Portfolio Table 39. AIDDISON Recent Development Table 40. Atomwise Inc Company Information Table 41. Atomwise Inc Business Overview Table 42. Atomwise Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio Table 44. Atomwise Inc Recent Development Table 45. BenevolentAI Company Information Table 46. BenevolentAI Business Overview Table 47. BenevolentAI AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio Table 49. BenevolentAI Recent Development Table 50. BullFrog AI Company Information Table 51. BullFrog AI Business Overview Table 52. BullFrog AI AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio Table 54. BullFrog AI Recent Development Table 55. Cyclica Company Information Table 56. Cyclica Business Overview Table 57. Cyclica AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Cyclica AI-Assisted Drug Discovery Software Product Portfolio Table 59. Cyclica Recent Development Table 60. Exscientia Company Information Table 61. Exscientia Business Overview Table 62. Exscientia AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Exscientia AI-Assisted Drug Discovery Software Product Portfolio Table 64. Exscientia Recent Development Table 65. Genesis Therapeutics Inc Company Information Table 66. Genesis Therapeutics Inc Business Overview Table 67. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio Table 69. Genesis Therapeutics Inc Recent Development Table 70. Insilico Medicine Company Information Table 71. Insilico Medicine Business Overview Table 72. Insilico Medicine AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio Table 74. Insilico Medicine Recent Development Table 75. Recursion Pharmaceuticals Company Information Table 76. Recursion Pharmaceuticals Business Overview Table 77. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio Table 79. Recursion Pharmaceuticals Recent Development Table 80. Verge Genomics Company Information Table 81. Verge Genomics Business Overview Table 82. Verge Genomics AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio Table 84. Verge Genomics Recent Development Table 85. North America AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) & (US$ Million) Table 86. North America AI-Assisted Drug Discovery Software Market Size by Type (2027-2032) & (US$ Million) Table 87. North America AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) & (US$ Million) Table 88. North America AI-Assisted Drug Discovery Software Market Size by Application (2027-2032) & (US$ Million) Table 89. North America AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) Table 91. North America AI-Assisted Drug Discovery Software Market Size by Country (2027-2032) Table 92. Europe AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe AI-Assisted Drug Discovery Software Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe AI-Assisted Drug Discovery Software Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) Table 98. Europe AI-Assisted Drug Discovery Software Market Size by Country (2027-2032) Table 99. China AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) & (US$ Million) Table 100. China AI-Assisted Drug Discovery Software Market Size by Type (2027-2032) & (US$ Million) Table 101. China AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) & (US$ Million) Table 102. China AI-Assisted Drug Discovery Software Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia AI-Assisted Drug Discovery Software Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia AI-Assisted Drug Discovery Software Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) Table 109. Asia AI-Assisted Drug Discovery Software Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. AI-Assisted Drug Discovery Software Product Image Figure 2. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI-Assisted Drug Discovery Software Market Share by Type: 2025 VS 2032 Figure 4. On Premise Software Image Figure 5. Cloud-Based Software Image Figure 6. Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global AI-Assisted Drug Discovery Software Market Share by Application: 2025 VS 2032 Figure 8. Biopharmaceuticals Image Figure 9. Pharmaceuticals Image Figure 10. Others Image Figure 11. Global AI-Assisted Drug Discovery Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 13. Global AI-Assisted Drug Discovery Software Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global AI-Assisted Drug Discovery Software Market Share by Players in 2025 Figure 16. Global Top 5 and 10 AI-Assisted Drug Discovery Software Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global AI-Assisted Drug Discovery Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI-Assisted Drug Discovery Software Revenue Market Share by Type (2021-2032) Figure 20. Global AI-Assisted Drug Discovery Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI-Assisted Drug Discovery Software Revenue Market Share by Application (2021-2032) Figure 22. North America AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 23. North America AI-Assisted Drug Discovery Software Market Share by Type (2021-2032) Figure 24. North America AI-Assisted Drug Discovery Software Market Share by Application (2021-2032) Figure 25. North America AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 26. United States AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 27. Canada AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 28. Mexico AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 29. Europe AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 30. Europe AI-Assisted Drug Discovery Software Market Share by Type (2021-2032) Figure 31. Europe AI-Assisted Drug Discovery Software Market Share by Application (2021-2032) Figure 32. Europe AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 33. Germany AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 34. France AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 35. U.K. AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 36. Italy AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 37. Russia AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 39. China AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 40. China AI-Assisted Drug Discovery Software Market Share by Type (2021-2032) Figure 41. China AI-Assisted Drug Discovery Software Market Share by Application (2021-2032) Figure 42. Asia AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 43. Asia AI-Assisted Drug Discovery Software Market Share by Type (2021-2032) Figure 44. Asia AI-Assisted Drug Discovery Software Market Share by Application (2021-2032) Figure 45. Asia AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 46. Japan AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 47. South Korea AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 50. India AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 51. Australia AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Country (2021-2032) Figure 56. Brazil AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 57. South Africa AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 59. Turkey AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 60. Argentina AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 61. UAE AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 62. Egypt AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 63. Chile AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • On Premise Software
  • Cloud-Based Software
Applications
  • Biopharmaceuticals
  • Pharmaceuticals
  • Others
Companies covered
  • AIDDISON
  • Atomwise Inc
  • BenevolentAI
  • BullFrog AI
  • Cyclica
  • Exscientia
  • Genesis Therapeutics Inc
  • Insilico Medicine
  • Recursion Pharmaceuticals
  • Verge Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 On Premise Software
  5. 1.2.3 Cloud-Based Software
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global AI-Assisted Drug Discovery Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Biopharmaceuticals
  9. 1.3.3 Pharmaceuticals
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global AI-Assisted Drug Discovery Software Growth Trends by Region
  13. 1.5.1 Global AI-Assisted Drug Discovery Software Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 AI-Assisted Drug Discovery Software Market Size by Region (2021-2026)
  15. 1.5.3 AI-Assisted Drug Discovery Software Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global AI-Assisted Drug Discovery Software Market Dynamics
  1. 2.1 AI-Assisted Drug Discovery Software Industry Trends
  2. 2.2 AI-Assisted Drug Discovery Software Industry Drivers
  3. 2.3 AI-Assisted Drug Discovery Software Industry Opportunities and Challenges
  4. 2.4 AI-Assisted Drug Discovery Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI-Assisted Drug Discovery Software Revenue by Company (2021-2026)
  2. 3.2 Global AI-Assisted Drug Discovery Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI-Assisted Drug Discovery Software Key Company Head office and Area Served
  4. 3.4 Global AI-Assisted Drug Discovery Software Company, Product Type & Application
  5. 3.5 Global AI-Assisted Drug Discovery Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI-Assisted Drug Discovery Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI-Assisted Drug Discovery Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI-Assisted Drug Discovery Software Tier 1, Tier 2, and Tier 3
4 AI-Assisted Drug Discovery Software Market by Type
  1. 4.1 Global AI-Assisted Drug Discovery Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI-Assisted Drug Discovery Software Market Size by Type (2021-2032)
  3. 4.3 Global AI-Assisted Drug Discovery Software Market Size Share by Type (2021-2032)
5 AI-Assisted Drug Discovery Software Market by Application
  1. 5.1 Global AI-Assisted Drug Discovery Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-Assisted Drug Discovery Software Market Size by Application (2021-2032)
  3. 5.3 Global AI-Assisted Drug Discovery Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AIDDISON
  2. 6.1.1 AIDDISON Company Information
  3. 6.1.2 AIDDISON Business Overview
  4. 6.1.3 AIDDISON AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AIDDISON AI-Assisted Drug Discovery Software Product Portfolio
  6. 6.1.5 AIDDISON Recent Developments
  7. 6.2 Atomwise Inc
  8. 6.2.1 Atomwise Inc Company Information
  9. 6.2.2 Atomwise Inc Business Overview
  10. 6.2.3 Atomwise Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio
  12. 6.2.5 Atomwise Inc Recent Developments
  13. 6.3 BenevolentAI
  14. 6.3.1 BenevolentAI Company Information
  15. 6.3.2 BenevolentAI Business Overview
  16. 6.3.3 BenevolentAI AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio
  18. 6.3.5 BenevolentAI Recent Developments
  19. 6.4 BullFrog AI
  20. 6.4.1 BullFrog AI Company Information
  21. 6.4.2 BullFrog AI Business Overview
  22. 6.4.3 BullFrog AI AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio
  24. 6.4.5 BullFrog AI Recent Developments
  25. 6.5 Cyclica
  26. 6.5.1 Cyclica Company Information
  27. 6.5.2 Cyclica Business Overview
  28. 6.5.3 Cyclica AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Cyclica AI-Assisted Drug Discovery Software Product Portfolio
  30. 6.5.5 Cyclica Recent Developments
  31. 6.6 Exscientia
  32. 6.6.1 Exscientia Company Information
  33. 6.6.2 Exscientia Business Overview
  34. 6.6.3 Exscientia AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Exscientia AI-Assisted Drug Discovery Software Product Portfolio
  36. 6.6.5 Exscientia Recent Developments
  37. 6.7 Genesis Therapeutics Inc
  38. 6.7.1 Genesis Therapeutics Inc Company Information
  39. 6.7.2 Genesis Therapeutics Inc Business Overview
  40. 6.7.3 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio
  42. 6.7.5 Genesis Therapeutics Inc Recent Developments
  43. 6.8 Insilico Medicine
  44. 6.8.1 Insilico Medicine Company Information
  45. 6.8.2 Insilico Medicine Business Overview
  46. 6.8.3 Insilico Medicine AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio
  48. 6.8.5 Insilico Medicine Recent Developments
  49. 6.9 Recursion Pharmaceuticals
  50. 6.9.1 Recursion Pharmaceuticals Company Information
  51. 6.9.2 Recursion Pharmaceuticals Business Overview
  52. 6.9.3 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio
  54. 6.9.5 Recursion Pharmaceuticals Recent Developments
  55. 6.10 Verge Genomics
  56. 6.10.1 Verge Genomics Company Information
  57. 6.10.2 Verge Genomics Business Overview
  58. 6.10.3 Verge Genomics AI-Assisted Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio
  60. 6.10.5 Verge Genomics Recent Developments
7 North America
  1. 7.1 North America AI-Assisted Drug Discovery Software Market Size (2021-2032)
  2. 7.2 North America AI-Assisted Drug Discovery Software Market Size by Type
  3. 7.2.1 North America AI-Assisted Drug Discovery Software Market Size by Type (2021-2026)
  4. 7.2.2 North America AI-Assisted Drug Discovery Software Market Size by Type (2027-2032)
  5. 7.2.3 North America AI-Assisted Drug Discovery Software Market Share by Type (2021-2032)
  6. 7.3 North America AI-Assisted Drug Discovery Software Market Size by Application
  7. 7.3.1 North America AI-Assisted Drug Discovery Software Market Size by Application (2021-2026)
  8. 7.3.2 North America AI-Assisted Drug Discovery Software Market Size by Application (2027-2032)
  9. 7.3.3 North America AI-Assisted Drug Discovery Software Market Share by Application (2021-2032)
  10. 7.4 North America AI-Assisted Drug Discovery Software Market Size by Country
  11. 7.4.1 North America AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  13. 7.4.3 North America AI-Assisted Drug Discovery Software Market Size by Country (2027-2032)
  14. 7.4.4 North America AI-Assisted Drug Discovery Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI-Assisted Drug Discovery Software Market Size (2021-2032)
  2. 8.2 Europe AI-Assisted Drug Discovery Software Market Size by Type
  3. 8.2.1 Europe AI-Assisted Drug Discovery Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI-Assisted Drug Discovery Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI-Assisted Drug Discovery Software Market Share by Type (2021-2032)
  6. 8.3 Europe AI-Assisted Drug Discovery Software Market Size by Application
  7. 8.3.1 Europe AI-Assisted Drug Discovery Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI-Assisted Drug Discovery Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI-Assisted Drug Discovery Software Market Share by Application (2021-2032)
  10. 8.4 Europe AI-Assisted Drug Discovery Software Market Size by Country
  11. 8.4.1 Europe AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI-Assisted Drug Discovery Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI-Assisted Drug Discovery Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI-Assisted Drug Discovery Software Market Size (2021-2032)
  2. 9.2 China AI-Assisted Drug Discovery Software Market Size by Type
  3. 9.2.1 China AI-Assisted Drug Discovery Software Market Size by Type (2021-2026)
  4. 9.2.2 China AI-Assisted Drug Discovery Software Market Size by Type (2027-2032)
  5. 9.2.3 China AI-Assisted Drug Discovery Software Market Share by Type (2021-2032)
  6. 9.3 China AI-Assisted Drug Discovery Software Market Size by Application
  7. 9.3.1 China AI-Assisted Drug Discovery Software Market Size by Application (2021-2026)
  8. 9.3.2 China AI-Assisted Drug Discovery Software Market Size by Application (2027-2032)
  9. 9.3.3 China AI-Assisted Drug Discovery Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI-Assisted Drug Discovery Software Market Size (2021-2032)
  2. 10.2 Asia AI-Assisted Drug Discovery Software Market Size by Type
  3. 10.2.1 Asia AI-Assisted Drug Discovery Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI-Assisted Drug Discovery Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI-Assisted Drug Discovery Software Market Share by Type (2021-2032)
  6. 10.3 Asia AI-Assisted Drug Discovery Software Market Size by Application
  7. 10.3.1 Asia AI-Assisted Drug Discovery Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI-Assisted Drug Discovery Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI-Assisted Drug Discovery Software Market Share by Application (2021-2032)
  10. 10.4 Asia AI-Assisted Drug Discovery Software Market Size by Country
  11. 10.4.1 Asia AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI-Assisted Drug Discovery Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI-Assisted Drug Discovery Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI-Assisted Drug Discovery Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst